Literature DB >> 1655672

In vivo and in vitro invasiveness of human lung carcinoma cell lines.

S Momiki1, M Baba, J Caamano, T Iizasa, M Nakajima, Y Yamaguchi, A Klein-Szanto.   

Abstract

Eight cell lines derived from human non-small cell lung carcinomas were used to compare their in vivo invasiveness, in vitro chemoinvasive abilities and type IV collagenase activity. For the evaluation of the in vivo invasive potential, the tumor cells were seeded into deepithelialized rat tracheas and transplanted subcutaneously into nude mice. The invasive behavior of the cells was observed at 4, 8 and 12 weeks and assessed histologically by determination of the levels of penetration of tumor cells into the different layers of the tracheal wall. Except for two cell lines that did not grow at all in vivo, there was a very good correspondence between the levels of in vivo tracheal wall penetration and the in vitro chemoinvasion assay using fibronectin as chemoattractant and Matrigel as barrier. This also correlated very well with the capacity of the cells to secrete type IV collagenase. The in vivo evaluation of invasion using tracheal transplants, although requiring several weeks of experimentation, proved to be very reliable, yielding homogeneous results with little internal variation, and is proposed as a dependable in vivo invasion assay that closely mimics the in vivo human conditions in which most carcinomas develop and eventually invade neighboring tissues.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1655672

Source DB:  PubMed          Journal:  Invasion Metastasis        ISSN: 0251-1789


  11 in total

1.  The architecture of cancer.

Authors:  J Waxman; H Wasan
Journal:  BMJ       Date:  1992-11-28

2.  Non-small-cell lung carcinoma cells invade human bronchial mucosa in vitro.

Authors:  L Fjellbirkeland; R Bjerkvig; O D Laerum
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-04       Impact factor: 2.416

3.  Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA.

Authors:  J Q Cheng; B Ruggeri; W M Klein; G Sonoda; D A Altomare; D K Watson; J R Testa
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

4.  Cathepsin B and cysteine proteinase inhibitors in human lung cancer cell lines.

Authors:  H H Heidtmann; U Salge; M Abrahamson; M Bencina; L Kastelic; N Kopitar-Jerala; V Turk; T T Lah
Journal:  Clin Exp Metastasis       Date:  1997-07       Impact factor: 5.150

5.  Mitochondria-to-nucleus stress signaling induces phenotypic changes, tumor progression and cell invasion.

Authors:  G Amuthan; G Biswas; S Y Zhang; A Klein-Szanto; C Vijayasarathy; N G Avadhani
Journal:  EMBO J       Date:  2001-04-17       Impact factor: 11.598

6.  Furin inhibition results in absent or decreased invasiveness and tumorigenicity of human cancer cells.

Authors:  D E Bassi; R Lopez De Cicco; H Mahloogi; S Zucker; G Thomas; A J Klein-Szanto
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

7.  p53 alterations in human squamous cell carcinomas and carcinoma cell lines.

Authors:  J Caamano; S Y Zhang; E A Rosvold; B Bauer; A J Klein-Szanto
Journal:  Am J Pathol       Date:  1993-04       Impact factor: 4.307

8.  Defects in mitochondrial fission protein dynamin-related protein 1 are linked to apoptotic resistance and autophagy in a lung cancer model.

Authors:  Kelly Jean Thomas; Marty R Jacobson
Journal:  PLoS One       Date:  2012-09-20       Impact factor: 3.240

9.  Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases.

Authors:  D A Arenberg; S L Kunkel; P J Polverini; S B Morris; M D Burdick; M C Glass; D T Taub; M D Iannettoni; R I Whyte; R M Strieter
Journal:  J Exp Med       Date:  1996-09-01       Impact factor: 14.307

10.  Increased furin activity enhances the malignant phenotype of human head and neck cancer cells.

Authors:  Daniel E Bassi; Haleh Mahloogi; Ricardo Lopez De Cicco; Andres Klein-Szanto
Journal:  Am J Pathol       Date:  2003-02       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.